## Abstract Previous studies have found an association between elevated second trimester maternal serum α‐fetoprotein (MS‐AFP), in the absence of fetal anomalies, and adverse pregnancy outcome. We studied the association between elevated second trimester maternal serum β‐HCG, now also routinely mea
Elevated second-trimester maternal serum hCG in patients undergoing haemodialysis
✍ Scribed by Po-Jen Cheng; Ching-Ming Liu; Shuenn-Dyh Chang; Yu-Ting Lin; Yung-Kwei Soong
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 102 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
✦ Synopsis
Prenatal Down syndrome screening with maternal serum alpha-fetoprotein (AFP) and human chorionic gonadotrophin (hCG) has become common. High levels of maternal serum hCG and low levels of AFP have been associated with an increased risk of fetal Down syndrome. In this paper, we report five pregnancies in patients undergoing long-term haemodialysis, all of whom had false-positive second-trimester Down syndrome screening results. All of our five patients had extremely high levels of maternal serum hCG, but normal AFP values for their gestational age, and all had serious complications during pregnancy.
📜 SIMILAR VOLUMES
This study was undertaken to investigate the association between placenta previa and Down syndrome screening analytesÐalpha-fetoprotein (AFP) and hCGÐduring the second trimester. Measurements of maternal serum AFP and hCG concentrations were retrospectively analysed in relation to placenta previa in
Objective: To establish normative data of maternal serum chorionic gonadotropin (hCG) during the second trimester in an Asian population. Methods: We measured the maternal serum hCG levels in 17,955 normal singleton pregnancies between 15 and 21 weeks of gestation. The gestation age was estimated by